Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model.
Page M, Stebbings R, Berry N, Hull R, Ferguson D, Davis L, Duffy L, Elsley W, Hall J, Ham C, Hassall M, Li B, Mee ET, Quartey-Papafio R, Rose NJ, Mathy N, Voss G, Stott EJ, Almond N.
Page M, et al. Among authors: hull r.
Retrovirology. 2012 Jul 16;9:56. doi: 10.1186/1742-4690-9-56.
Retrovirology. 2012.
PMID: 22799593
Free PMC article.